journal article·2019-12-24

Biodegradable Manganese-Doped Calcium Phosphate Nanotheranostics for Traceable Cascade Reaction-Enhanced Anti-Tumor Therapy

Lian-Hua Fu, Yan-Ru Hu, Chao Qi, Ting He, Shanshan Jiang, Chao Jiang, Jin He, Junle Qu, Jing Lin, Peng Huang

ACS Nano· Volume 13· Issue 12
Publisher page

Abstract

Glucose oxidase (GOx) has been recognized as a “star” enzyme catalyst involved in cancer treatment in the past few years. Herein, GOx is mineralized with manganese-doped calcium phosphate (MnCaP) to form spherical nanoparticles (GOx-MnCaP NPs) by an in situ biomimetic mineralization method, followed by the loading of doxorubicin (DOX) to construct a biodegradable, biocompatible, and tumor acidity-responsive nanotheranostics for magnetic resonance imaging (MRI) and cascade reaction-enhanced cooperative cancer treatment. The GOx-driven oxidation reaction can effectively eliminate intratumoral glucose for starvation therapy, and the elevated H2O2 is then converted into highly toxic hydroxyl radicals via a Mn2+-mediated Fenton-like reaction for chemodynamic therapy (CDT). Moreover, the acidity amplification due to the gluconic acid generation will in turn accelerate the degradation of the nanoplatform and promote the Mn2+–H2O2 reaction for enhanced CDT. Meanwhile, the released Mn2+ ions can be used for MRI to monitor the treatment process. After carrying the anticancer drug, the DOX-loaded GOx-MnCaP can integrate starvation therapy, Mn2+-mediated CDT, and DOX-induced chemotherapy together, which showed greatly improved therapeutic efficacy than each monotherapy. Such an orchestrated cooperative cancer therapy demonstrated high-efficiency tumor suppression on 4T1 tumor-bearing mice with minimal side effects. Our findings suggested that the DOX-loaded GOx-MnCaP nanotheranostics with excellent biodegradability and biocompatibility hold clinical translation potential for cancer management.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Nanoplatforms for cancer theranostics · Nanoparticle-Based Drug Delivery · Advanced Nanomaterials in Catalysis

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Marshall Laboratory of Biomedical Engineering, International Cancer Center, Laboratory of Evolutionary Theranostics (LET), School of Biomedical Engineering, Health Science Center, Shenzhen University, Shenzhen 518060, China

Key Laboratory of Optoelectronic Devices and Systems of Ministry of Education and Guangdong Province, College of Optoelectronic Engineering, Shenzhen University, Shenzhen 518060, China

Funding

Ministry of Science and Technology of the People's Republic of China · China Postdoctoral Science Foundation · Fok Ying Tong Education Foundation · National Natural Science Foundation of China · Natural Science Foundation of Guangdong Province · Shenzhen Municipality

References (36)

Show source-provided references
1. 10.1038/nnano.2016.28010.1038/nnano.2016.280 ↗
2. 10.1038/nbt.407110.1038/nbt.4071 ↗
3. 10.1039/C7CS00891K10.1039/C7CS00891K ↗
4. 10.1016/j.biotechadv.2009.04.00310.1016/j.biotechadv.2009.04.003 ↗
5. 10.1002/anie.20161068210.1002/anie.201610682 ↗
6. 10.1039/C8MH00908B10.1039/C8MH00908B ↗
7. 10.1021/acs.nanolett.8b0317810.1021/acs.nanolett.8b03178 ↗
8. 10.1002/adma.20180832510.1002/adma.201808325 ↗
9. 10.1021/acs.chemrev.7b0025810.1021/acs.chemrev.7b00258 ↗
10. 10.1002/anie.20180566410.1002/anie.201805664 ↗
11. 10.1021/acsnano.8b0763510.1021/acsnano.8b07635 ↗
12. 10.1002/ange.20151003110.1002/ange.201510031 ↗
13. 10.1002/anie.20171202710.1002/anie.201712027 ↗
14. 10.1021/acsnano.8b0938710.1021/acsnano.8b09387 ↗
15. 10.1038/s41467-017-00424-810.1038/s41467-017-00424-8 ↗
16. 10.1021/acsnano.8b0504210.1021/acsnano.8b05042 ↗
17. 10.1021/acsnano.8b0908210.1021/acsnano.8b09082 ↗
18. 10.1002/adma.20180591910.1002/adma.201805919 ↗
19. 10.1002/adma.20160590310.1002/adma.201605903 ↗
20. 10.1039/C6CS00746E10.1039/C6CS00746E ↗
21. 10.1039/C8CS00489G10.1039/C8CS00489G ↗
22. 10.7150/thno.1468910.7150/thno.14689 ↗
23. 10.7150/thno.3730110.7150/thno.37301 ↗
24. 10.1039/C5CC01420D10.1039/C5CC01420D ↗
25. 10.1002/anie.20120615410.1002/anie.201206154 ↗
26. 10.1021/acsnano.7b0180910.1021/acsnano.7b01809 ↗
27. 10.1038/s41467-017-01764-110.1038/s41467-017-01764-1 ↗
28. 10.1021/acs.nanolett.9b0057910.1021/acs.nanolett.9b00579 ↗
29. 10.1021/acsami.8b2095610.1021/acsami.8b20956 ↗
30. 10.1126/science.106318710.1126/science.1063187 ↗
31. 10.1007/s00216-010-3996-x10.1007/s00216-010-3996-x ↗
32. 10.1016/j.biomaterials.2016.12.03110.1016/j.biomaterials.2016.12.031 ↗
33. 10.1039/C5TB01340B10.1039/C5TB01340B ↗
34. 10.1021/acs.nanolett.7b0138210.1021/acs.nanolett.7b01382 ↗
35. 10.1021/acs.nanolett.8b0476310.1021/acs.nanolett.8b04763 ↗
36. 10.1016/j.biomaterials.2019.04.02310.1016/j.biomaterials.2019.04.023 ↗